Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JP Morgan raises target price on Trustpilot

(Sharecast News) - Analysts at JP Morgan raised their target price on review website operator Trustpilot from 190.0p to 250.0p on Tuesday, stating earnings momentum looked set to continue as the group transitions into a fast-growing free cashflow generator. JP Morgan stated that since it upgraded Trustpilot to 'overweight' from 'neutral' in February 2023, guidance has been upgraded four times, driving earnings and FCF estimates upward.

"Shares are up ~125% in the last six months and investors we interact with are increasingly focussed on where incremental upside comes from," noted JPM.

The broker reexamined its investment thesis on Trustpilot and took "a refreshed view" on what drives performance from here.

"Looking forward, we see earnings supported by: 1) Further operational leverage to come, driving continued momentum in earnings upgrades; 2) Manageable top-line estimates through 2024; 3) Conservative FCF consensus outlook through 2024, supported by Trustpilot's negative working capital profile; 4) Trustpilot well positioned as a GenAI winner," said JPM.

It also stated it sees valuation support from Trustpilot's ongoing share buyback programme, as well as a continued beat and raise cadence under new management, with a focus on profitable growth, and a supportive bond yield environment.

"We increase our underlying EBITDA estimates ~13-16% and raise our PT to 250p, continuing to see Trustpilot as a unique asset well positioned for multi-year profitable growth (JPMe ~54% FCF CAGR 2023-2026)," concluded JPM.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.